E Engelsman

1.2k total citations
37 papers, 940 citations indexed

About

E Engelsman is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, E Engelsman has authored 37 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in E Engelsman's work include Estrogen and related hormone effects (13 papers), Breast Cancer Treatment Studies (8 papers) and Cancer Treatment and Pharmacology (7 papers). E Engelsman is often cited by papers focused on Estrogen and related hormone effects (13 papers), Breast Cancer Treatment Studies (8 papers) and Cancer Treatment and Pharmacology (7 papers). E Engelsman collaborates with scholars based in Netherlands, Belgium and France. E Engelsman's co-authors include Augustinus A. M. Hart, Willem Boogerd, J.-P. Persijn, F. J. Cleton, Richard Sylvester, Nicole Rotmensz, J. Wildiers, R.D. Rubens, M. Nooij and M. De Jong‐Bakker and has published in prestigious journals such as The Lancet, Cancer and British Journal of Cancer.

In The Last Decade

E Engelsman

36 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Engelsman Netherlands	16	519	359	238	236	117	37	940
Katherine DeSchryver United States	15	441 0.8×	441 1.2×	218 0.9×	269 1.1×	194 1.7×	29	1.1k
J. Benraadt Netherlands	9	440 0.8×	233 0.6×	636 2.7×	333 1.4×	77 0.7×	13	1.3k
J. Alexieva-Figusch Netherlands	15	596 1.1×	326 0.9×	516 2.2×	172 0.7×	55 0.5×	30	1.1k
Ritva Valavaara Finland	14	293 0.6×	223 0.6×	406 1.7×	134 0.6×	50 0.4×	29	900
Audrey Barlock United States	12	487 0.9×	380 1.1×	451 1.9×	146 0.6×	166 1.4×	13	1.0k
S Kumaoka Japan	13	1.1k 2.1×	602 1.7×	553 2.3×	295 1.3×	195 1.7×	33	1.9k
A Demaille France	17	437 0.8×	231 0.6×	187 0.8×	75 0.3×	70 0.6×	74	954
J Askergren Sweden	15	492 0.9×	530 1.5×	705 3.0×	99 0.4×	273 2.3×	26	1.4k
Ermelinda De Maio Italy	16	533 1.0×	284 0.8×	217 0.9×	235 1.0×	92 0.8×	30	1.1k
Fernando Lara-Medina Mexico	17	487 0.9×	411 1.1×	159 0.7×	198 0.8×	145 1.2×	40	906

Countries citing papers authored by E Engelsman

Since Specialization

Citations

This map shows the geographic impact of E Engelsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Engelsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Engelsman more than expected).

Fields of papers citing papers by E Engelsman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Engelsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Engelsman. The network helps show where E Engelsman may publish in the future.

Co-authorship network of co-authors of E Engelsman

This figure shows the co-authorship network connecting the top 25 collaborators of E Engelsman. A scholar is included among the top collaborators of E Engelsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Engelsman. E Engelsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boogerd, Willem, et al.. (1991). Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer. 67(6). 1685–1695. 159 indexed citations

Engelsman, E, R.D. Rubens, J. Wildiers, et al.. (1991). “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. European Journal of Cancer and Clinical Oncology. 27(8). 966–970. 122 indexed citations

Rubens, R.D., Harry Bartelink, E Engelsman, et al.. (1989). Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy. European Journal of Cancer and Clinical Oncology. 25(4). 667–678. 73 indexed citations

Hoefnagel, C.A., P.A. Voûte, Jan de Kraker, et al.. (1988). Side effects of I-131-MIBG therapy of neural crest tumors. Australian and New Zealand Journal of Medicine. 18(3). 504. 1 indexed citations

Eisenstein, Zemach, E Engelsman, M.S. Weiss, Yona Kalechman, & Benjamin Sredni. (1988). Production of and response to interleukin-2 in Graves' disease. Journal of Clinical Immunology. 8(5). 349–355. 17 indexed citations

Pa, Voûte, et al.. (1988). [Diagnosis and therapy of neural crest tumors using I131 iodobenzylguanidine].. PubMed. 132(29). 1367–72. 2 indexed citations

Schaberg, A, et al.. (1985). Placental-Site Trophoblastic Tumor. International Journal of Gynecological Pathology. 4(1). 75–82. 13 indexed citations

Engelsman, E, et al.. (1984). Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer. Breast Cancer Research and Treatment. 4(4). 289–295. 16 indexed citations

Sylvester, Richard, et al.. (1980). Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.. PubMed. Suppl 1. 113–7. 4 indexed citations

10.

Engelsman, E, et al.. (1979). Pilot Study on Adjuvant Chemotherapy and Hormonal Therapy for Irradiated Inoperable Breast Cancer. Recent results in cancer research. 68. 113–117. 2 indexed citations

11.

Engelsman, E, Jean-Claude Heuson, A Drochmans, et al.. (1975). Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.. BMJ. 2(5973). 714–715. 24 indexed citations

12.

Heuson, Jean-Claude, et al.. (1975). Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.. BMJ. 2(5973). 711–713. 44 indexed citations

13.

Persijn, J.-P., et al.. (1975). Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.. BMJ. 4(5995). 503–503. 43 indexed citations

14.

Engelsman, E, et al.. (1974). ANTI-ŒSTROGENS AND BREAST CANCER. The Lancet. 304(7873). 171–172. 1 indexed citations

15.

Engelsman, E. (1974). Proceedings: Clinical value of predictive tests for advanced breast cancer. British Journal of Cancer. 30(2). 189–190. 1 indexed citations

16.

Engelsman, E, et al.. (1974). Proceedings: Oestrogen and androgen receptors in human breast cancer. British Journal of Cancer. 30(2). 177–177. 16 indexed citations

17.

Engelsman, E, et al.. (1973). Oestrogen Receptor in Human Breast Cancer Tissue and Response to Endocrine Therapy. BMJ. 2(5869). 750–752. 62 indexed citations

18.

Engelsman, E, et al.. (1973). Human breast cancer and estrogen receptor.. PubMed. 25(4). 393–7. 5 indexed citations

19.

Slik, W. van der, J.-P. Persijn, E Engelsman, & A. Riethorst. (1970). Serum 5′-Nucleotidase. Clinical Biochemistry. 3(1). 59–80. 13 indexed citations

20.

Brakman, Pieter, et al.. (1959). Deterioration of AHG (Factor VIII) and Fibrinolysis. Thrombosis and Haemostasis. 3(1). 1–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact